Invasive Fungal Infections
📧 Sign up to get email alerts when something new happens for Invasive Fungal Infections.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2011-06-28FDA Approved: FLUCYTOSINE — Original Application (Sigmapharm Laboratories, LLC)
FDA approved a generic version of Flucytosine from Sigmapharm Laboratories via an original ANDA.
-
CLINICAL_TRIALS trial_result · 2010-08-11Clinical Trial Update: Open, Non Comparative Study Of Voriconazole In Slovak Patients With Very High Risk Of Developing An Invasive Fungal Infection
An open, non-comparative study evaluating voriconazole in Slovak patients at very high risk of developing invasive fungal infections was com…
-
CLINICAL_TRIALS trial_result · 2010-03-10Clinical Trial Update: Voriconazole Versus Itraconazole In Primary Prophylaxis Of Invasive Fungal Infection (IFI) In Subjects With Allogeneic Hematopoietic Stem Cell Transplants (HSCT) [Phase 3]
Phase 3 trial comparing voriconazole to itraconazole for primary prophylaxis of invasive fungal infections in allogeneic hematopoietic stem …
-
FDA approval · 2010-03-05FDA Approved: AMPHOTERICIN B — Supplemental Application (XGen Pharmaceuticals DJB, Inc.)
FDA approved a supplemental application for Amphotericin B submitted by XGen Pharmaceuticals DJB, Inc. This approval authorizes a change to …
-
CLINICAL_TRIALS trial_result · 2009-06-01Clinical Trial Update: Voriconazole for Secondary Prophylaxis of Invasive Fungal Infections in Patients With Allogeneic Stem Cell Transplants [Phase 4]
Phase 4 trial evaluating voriconazole as secondary prophylaxis against invasive fungal infections in allogeneic stem cell transplant recipie…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2008-12-17Clinical Trial Update: Limited Access Protocol of Posaconazole in Invasive Fungal Infections Study PO2095 [Phase 4]
The Phase 4 Limited Access Protocol study PO2095 evaluating posaconazole for invasive fungal infections has been terminated, with no further…
-
CLINICAL_TRIALS trial_result · 2008-06-12Clinical Trial Update: A Study To Assess The Efficacy And Safety Of Voriconazole In Chinese Patients With Serious Deep Tissue Fungal Infections [Phase 4]
Pfizer-sponsored Phase 4 study evaluating the efficacy and safety of voriconazole in Chinese patients with serious deep tissue fungal infect…
-
FDA approval · 2006-09-15FDA Approved: NOXAFIL — Original Application (Merck Sharp & Dohme LLC)
NOXAFIL (posaconazole) received FDA approval through its original application as a broad-spectrum antifungal agent for the prevention of inv…
-
FDA label_change · 2006-05-19FDA Approved: VFEND — Supplemental Application (Roerig)
FDA approved a supplemental application for VFEND (voriconazole) submitted by Roerig, updating the product labeling.